• Home
  • About
  • News
  • Events
  • Shop
  • Directory
  • Contact Us
Search
Sign in
Welcome! Log into your account
Forgot your password? Get help
Password recovery
Recover your password
A password will be e-mailed to you.
PsyNews.com
  • Home
  • About
  • News
  • Events
  • Shop
  • Directory
  • Contact Us
Home Authors Posts by Watertime

Watertime

255 POSTS 0 COMMENTS

2 Massachusetts Cities Have Decriminalized Psychedelics in the Last Month

Interview With Dr. Hyder A. Khoja

5-MeO-DMT: Can ‘Toad Juice’ Cure Depression?

The World’s First Psychedelic ETF Just Launched: Here’s Why That Matters

How Red Light Holland Is Bringing Psilocybin Truffles Mainstream

Feb 10: $SPOR +40.91%, $PSYC +35.42%, $MCUR +23.33%

The Critical Role of Patents in Novel Drug Development

In Another Historic First for Psychedelics, The World’s First Psychedelic ETF...

Psychedelics Versus Cannabis: Exploring their Impact on Treating Mental Illness

Progressive Law Firm Zuber Lawler Is at Forefront of Modern Psychedelic...

1...212223...26Page 22 of 26

EDITOR PICKS

Advanced Shadow Work and Psychedelic Integration: A Jungian Path to Wholeness

Essentials of Psychedelic Therapy & Integration

Pα+ Psychedelic Bulletin #206: Q2’25 Psychedelic Lobbying; Tabernanthalog’s Neuroplasticity Pathway; UK...

POPULAR POSTS

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

POPULAR CATEGORY

    ABOUT US
    PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.
    FOLLOW US
    ©